Our findings showed that four components (C1QB, C1QC, C4BPA, and C4BPB) of the complement system were significantly upregulated in the sEVs from the HCC group compared to the control group, which may be a novel discovery in HCC. The gene discussed is C4BPA; the disease is hepatocellular carcinoma.